To further explore the potential cellular pathways mediated by CLRs in bladder cancer, we performed a gene ontology (GO) enrichment pathway prediction analysis based on the previously obtained differentiated genes (Figures 3E–H). The gene discussed is LARS1; the disease is urinary bladder carcinoma.